CeMM stands in solidarity with Ukraine
CeMM strongly condemns the invasion of Ukraine and wholeheartedly wishes to express solidarity with the Ukrainian people in these difficult times. Together with the Austrian Academy of Sciences and our partners in the EU-LIFE alliance, we would like to support the scientific community in Ukraine. CeMM supports the following initiatives for scientists from Ukraine: EMBO's Solidarity with Ukraine: A list of life scientists across Europe and…
CeMM bids farewell to Thijn Brummelkamp
Adjunct Principal Investigator Thijn Brummelkamp’s affiliation came to an end after having been associated with CeMM for ten years. We would like to sincerely thank him for a great collaboration on the scientific front and fruitful exchanges and constant engagement with the CeMM community. Thijn Brummelkamp received his Msc in biology from the Free University in Amsterdam in 1998. He did his graduate research at The Netherlands Cancer Institute…
Become a Starting Principal Investigator at CeMM in Vienna
Research Area: Biology of Human Aging/Healthy Lifespan Expansion The time is ripe for brand new approaches to the phenomenon of human aging and the ambition of healthy lifespan expansion. Access to large deep phenotypic and genomic datasets and new powerful imaging, molecular and computational approaches call for initiatives in an area that for a long time has been captive of single mechanistic theories. At CeMM, we propose a completely fresh…
New methods for network visualizations enable change of perspectives and views
When visualizing data using networks, the type of representation is crucial for extracting hidden information and relationships. The research group of Jörg Menche, Adjunct Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Professor at the University of Vienna, and Group leader at Max Perutz Labs, developed a new method for generating network layouts that allow for visualizing different…
Advancing genome editing through studying DNA repair mechanisms
Prime editing is an improved variant of the CRISPR/Cas system that can introduce alterations in DNA with exquisite precision. But the method is complex and inefficient. The research group of Joanna Loizou, at the Medical University of Vienna (MedUni Vienna) and CeMM, has now been able to show that the DNA mismatch repair process plays an essential role in prime editing. Since the discovery of CRISPR/Cas9, also known as molecular scissors,…
Monica Bettencourt-Dias (IGC) and Giulio Superti-Furga (CeMM) appointed new chair and co-chair of EU-LIFE
Monica Bettencourt-Dias, Director of Instituto Gulbenkian de Ciência (IGC, Portugal), and Giulio Superti-Furga, Scientific Director of the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, have been appointed new Chair and Co-Chair respectively of EU-LIFE, the alliance of fifteen leading life science institutes in Europe, as of 1 January 2022. During the next two years they will be working closely with Marta…
Andreas Bergthaler becomes Professor for Molecular Immunology at MedUni Vienna, and CeMM Adjunct Principal Investigator
On 1 January 2022, Andreas Bergthaler and his team members will join the Center for Pathophysiology, Infectiology and Immunology at the Medical University of Vienna. There, Andreas will head the Institute for Hygiene and Applied Immunology. He will now become an Adjunct Principal Investigator at CeMM. Andreas Bergthaler studied veterinary medicine at the University of Veterinary Medicine in Vienna. For his graduate studies, he joined the…
Season Greetings 2021
At the beginning of the pandemic, we optimistically hailed the "scientification of society” a so-called “Verwissenschaftlichung der Gesellschaft” as a positive Corona side effect. Multiple Covid vaccines within a year and tailored medicines represent a triumph for research and innovation. Yet, at a time in history when humanity's inventiveness is impressively evidenced, the status of science in society is surprisingly low. We would like to see a…
Specific metabolic dependencies of cancer cells revealed by perturbation with tailored chemical library offer new therapeutic possibilities
Many types of cancer exhibit changes in their cellular metabolism. These contribute to the development and progression of cancer. Metabolic reprogramming has, thus, been recognized as a hallmark of cancer and may thus represent a vulnerability to be exploited by targeted cancer therapy. Scientists from the research group of Giulio Superti-Furga, Scientific Director at the CeMM Research Center for Molecular Medicine of the Austrian Academy of…
Kaan Boztug takes over professorship in the subject field Paediatrics and Inflammation Research in MedUni Vienna
CeMM Principal Investigator Kaan Boztug, consultant in paediatrics and adolescent medicine and internationally renowned expert in rare haematopoietic and immunological diseases, has accepted a professorship (§ 99 Para. 4 UG) in the subject field Paediatrics and Inflammation Research at the Medical University of Vienna's Department of Pediatrics and Adolescent Medicine with effect from 01 December 2021. During the course of his medical and…
From the god of sun to immunodeficiency: international research team identifies new rare disease affecting hematopoiesis and immunity
A disturbed Helios-dependent epigenetic regulation mechanism causes T and B cell defects in an inborn immune disease. Together with international collaborators, scientists at the St. Anna Children’s Cancer Research Institute discover a new inborn error of hematopoiesis and immunity, caused by an inherited genetic defect of the transcription factor Helios. In their research project, the team was able to define previously unknown roles of Helios…
Prompt initiation of antiretroviral therapy reduces cancer risk in HIV patients
HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy. A new study by MedUni Vienna's Department of Dermatology, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD) and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences now shows that the time of starting antiretroviral therapy can…
Multiplex network improves diagnosis and analysis of rare diseases
Rare diseases are usually caused by a single genetic defect. Nevertheless, the search for the cause and the assessment of the effects is highly complex and difficult. Scientist Jörg Menche, Adjunct Principal Investigator at the CeMM, Professor at the University of Vienna and Research Group Leader at the Max Perutz Labs, and his team have now developed a multiplex network that maps all genes and their interactions on multiple levels and improves…
1st REsolution Consortium Meeting 21 October 2021
On 21 October 2021, the REsolution consortium held its first consortium meeting online with 30 participants. The REsolution consortium is a public-private research partnership supported by the Innovative Medicines Initiative (IMI), the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA), with nine partners from academia and the pharmaceutical industry. With a duration of two years, the project aims at…
Artist Adriana Czernin designed chair’s backrest for CeMM’s Brain Lounge
On 19 October 2021, CeMM welcomed artist Adriana Czernin for the inauguration of the new chair’s backrest that she has specially designed for CeMM’s Brain Lounge. During the event, Adriana Czernin presented her piece of art entitled “4-sided 3-angle”, and discussed with CeMM PhD students the design process, and the combination of abstract art with the idea of perspective in her work. CeMM’s Brain Lounge is located on the 8th floor of CeMM’s…
